title: A case of rivaroxaban associated intracranial hemorrhage.
abstract: Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat nonvalvular atrial fibrillation. Rivaroxaban has several characteristics that are more favorable than warfarin. One of the characteristics is decreased risk of hemorrhage. We report one of the first case reports of severe intracranial hemorrhage associated with rivaroxaban in an elderly patient with decreased renal function. We aim to alert emergency medicine providers regarding the likelihood of encountering these patient as newer anticoagulants rise in popularity.
authors.affiliation: Loma Linda University, Department of Emergency Medicine, Loma Linda, California.
authors.forename: Jean Chin-Yu
authors.initials: JC
authors.lastname: Lo
authors.affiliation: University of California San Francisco, Department of Laboratory Medicine, San Francisco, California.
authors.forename: Roy R
authors.initials: RR
authors.lastname: Gerona
mesh_terms: D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D065427:Factor Xa Inhibitors / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D000069552:Rivaroxaban; D020521:Stroke / Q000188:drug therapy / Q000209:etiology; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban